How much funding has Hotspot Therapeutics raised?

Hotspot Therapeutics has raised $210.0M in total funding, most recently a Series A round.

When was Hotspot Therapeutics founded?

Hotspot Therapeutics was founded in 2017.

Where is Hotspot Therapeutics headquartered?

Hotspot Therapeutics is headquartered in Boston, United States.

What industry is Hotspot Therapeutics in?

Hotspot Therapeutics operates in Biotech, Healthcare.

How many employees does Hotspot Therapeutics have?

Hotspot Therapeutics has 11-50 employees.

Hotspot Therapeutics

Boston, United States · Founded 2017 · $210.0M raised

Biotech

Healthcare

Headquarters: Boston
Employees: 11–50
Founded: 2017
Business Model: B2B

Website: hotspotthera.com
Total Funding: $210.0M
Last Round: $45.0M Series ANov 2021
Rounds: 3

About

HotSpot Therapeutics is a clinical-stage biotech company pioneering allosteric drug discovery through its Smart Allostery platform, which identifies natural regulatory hotspots on proteins remote from the active site. Founded in 2017 by Jonathan Montagu and Geraldine Harriman in Cambridge, Massachusetts, the company is developing novel small-molecule therapies for cancer and autoimmune diseases including lupus.

Summary

Hotspot Therapeutics is a Biotech company based in Boston, United States, founded in 2017. It has raised $210.0M in total across 3 rounds, most recently a $45.0M Series A round in Nov 2021.